LegalView is Proud to Announce the Launch of New FDA Notification Service

Share Article

LegalView recently launched its U.S. Food and Drug Administration (FDA) notification service, which will allow individuals suffering from negative pharmaceutical side effects to voice their concerns directly to the FDA. LegalView currently offers a vast plentitude of practice areas relating to adverse pharmaceutical side effects but now readers will be able to take immediate action.

Report Your Case to the FDA

LegalView, the premier resource on the Web for everything legal, is proud to announce a new feature on its many information portals dealing with pharmaceuticals that pose a recognized public-safety threat. Individual readers will now be able to submit their concerns on featured LegalView controversial drugs directly to the U.S. Food and Drug Administration (FDA) via LegalView's information portals. Currently, LegalView hosts over 50 such information portals with useful and pertinent information on drugs, including sites relating to the recent Heparin recall, type 2 diabetes drug Avandia risks or anti-smoking aid Chantix side effects. All of LegalView's drug information portals provide information on the drug, possible side effects as well as help in contacting a law firm or attorney experienced in dealing with drug litigation. In addition to these specific drug information portals, LegalView also hosts hundreds of DrugWatch information portals that monitor the status of potentially harmful pharmaceuticals, in order to ensure that the public is always kept up to date.

As a testament to the broad appeal and desire for experienced counsel all the pharmaceuticals covered in the drug and DrugWatch portals, LegalView readers have submitted over 10,000 requests for more information since the launch of the drug portals in 2005. With each information request, a qualified attorney from one of LegalView's sponsoring law firms reviewed the individual's concerns and responded to their questions with relevant legal information and counsel. As a result of this overwhelming public response, LegalView is proud to announce the FDA reporting feature on all controversial drugs and DrugWatch portals. By clicking the "Report Your Case to the FDA" link, readers will be able to access the FDA MedWatch Online Voluntary Reporting form. Using this form, the reader can take a proactive step to ensure that the FDA drug database has the details of their individual case, which will enable the FDA to make better decisions regarding public safety as a whole.

In addition to the controversial drugs and DrugWatch information portals, LegalView is also proud to host a vast plentitude of portals relating to other legal issues affecting Americans today. On LegalView's traumatic brain injury information portal, readers can get information on brain injury symptoms and treatments, as well as read about what can go into filing a brain injury lawsuit. With the LegalView mesothelioma site, individuals can peruse in-depth information on the deadly cancer, as well as get help contacting a mesothelioma lawyer for help with filing a mesothelioma lawsuit. In addition to these key practice areas, LegalView is also pleased to offer dozens of other content for concerns ranging from faulty consumer goods to environmental toxins to medical malpractice issues.

About LegalView:
LegalView.com is a free public service brought to you by Legal WebTV Network, LLC, a Limited Liability Corporation created by a national group of distinguished law firms: Anapol Schwartz; Brent Coon and Associates; Burg Simpson; Cohen, Placitella and Roth; James F. Humphreys and Associates; Lopez McHugh; and Thornton and Naumes. For more information on the accomplishments and track records of LegalView.com's sponsoring law firms and to get in touch with LegalView attorneys, visit LegalView at http://www.Legalview.com.

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Katie Kelley

Alan Haburchak
Visit website